Professor Kirsten Howard

BSc (Hons1), MAppSc(Biopharm), MPH, MHlthEc, PhD, FAHMS

Kirsten Howard (BSc (Hons1), MAppSc(Biopharm), MPH, MHlthEc, PhD, FAHMS) is Co-Director of the Menzies Centre for Health Policy and Economics and Professor of Health Economics, in the School of Public Health. She has more than 25 years experience in health economics and health policy research, with a focus on patient and consumer preferences, QOL/wellbeing measurement and economic evaluation. She has worked in diverse public health areas such as cancer screening, falls prevention, chronic kidney disease, organ donation and allocation policy, child quality of life measurement and in Aboriginal and Torres Strait Islander health and wellbeing. She co-leads the NHMRC-funded What Matters 2 Adults (WM2A) and the MRFF-funded What Matters 2 Youth (WM2Y) projects to develop new nationally-relevant preference-based wellbeing measures for Aboriginal and Torres Strait Islander adults and youth, and a MRFF implementation study for the What Matters measure (WM2A) in routine PRMs collection in NSW cancer services.

She is Chair of the Economics Sub Committee of the Pharmaceutical Benefits Advisory Committee (PBAC) and a member of the PBAC. She is a member of the NSW Agency for Clinical Innovation (ACI) Advisory Committee for the evaluation of the NSW Health Patient Report Measures Program. She was previously a Board Director of the International Academy of Health Preference Research. She has >370 publications including >275 peer-reviewed publications, 40 policy reports, and is a recognised international expert in the field of patient and consumer preference evaluation. Professor Kirsten Howard (sydney.edu.au)